Thanks kip. Do you mind if I ask a question? I'm used to waiting...

Thanks kip. Do you mind if I ask a question? I'm used to waiting on a biotech to get FDA approval to unlock the vault to riches. The trials they do involve large numbers to satisfy the FDA requirements. Is EMS looking for FDA approval with such small patient trials?

I guess their market would probably be in countries that don't need FDA approval so are they just following rules set by those African countries they are testing in?

I may have just answered my own question.

There was an article in the NYT today about GSK trialing a malaria drug but their success rate was 46% or something like that. The Gates Foundation is behind them though. It isn't targeted for market (if ever) until 2014 though.